About 100 reports

  • Cancer supportive care market in EMEA
  • 3.2 Information sources
  • Cancer
  • Therapy
  • Amgen Inc.
  • Helsinn Group
  • Merck & Co., Inc.
  • Stages of bladder cancer
  • Bladder cancer therapeutics market in Americas
  • Cancer
  • United States
  • Forecast
  • Market Size
  • Merck & Co., Inc.
  • MODERATE GROWTH IN THE COLORECTAL CANCER MARKET EXPECTED FROM 2015 THROUGH 2025
  • COLORECTAL CANCER: KEY METRICS IN SEVEN MAJOR PHARMACEUTICAL MARKETS
  • Cancer
  • Colorectal Cancer
  • Hospital
  • Therapy
  • Merck & Co., Inc.
  • LUNG CANCER THERAPEUTICS MARKET IN EMEA
  • MARKET PENETRATION OF VARIOUS LUNG CANCER THERAPEUTICS MANUFACTURERS IN GLOBAL (2015)
  • Cancer
  • Lung Cancer
  • AstraZeneca PLC
  • Celgene Corporation
  • Merck & Co., Inc.
  • Executive Summary
  • EARLY-STAGE CLINICAL DEVELOPMENT IN NSCLC

CANCER.

  • Cancer
  • Hospital
  • Lung Cancer
  • Therapy
  • Merck & Co., Inc.
  • 10.3 ADVAXIS
  • 10.26 ONCOTHYREON

CANCER VACCINES MARKET - REGIONAL ANALYSIS TO 2020 United States - Cancer Vaccines Market Europe - Cancer Vaccines Market Asia - Cancer Vaccines Market ##.

  • Cancer
  • Cancer Immunotherapy
  • Therapy
  • Vaccine
  • Merck & Co., Inc.
  • BLADDER CANCER: KEY METRICS IN THE 7MM
  • 2 Bladder Cancer: Executive Summary
  • Bladder Cancer
  • Cancer
  • Therapy
  • Europe
  • Merck & Co., Inc.
  • Executive Summary
  • Untitled

High-risk HPV types cause approximately ##% of all cancers worldwide - it is thought to account for ##% of anal cancers, ##% of oropharyngeal cancers, ##% of vaginal cancers, ##% of vulvar cancers, and ##% of penile cancers.

  • Cancer
  • Cancer Immunotherapy
  • Therapy
  • Vaccine
  • Merck & Co., Inc.
  • 9.1.3 INVESTIGATIONAL NEW DRUG/CLINICAL TRIAL AUTHORIZATION-FILED
  • Introduction

Colorectal cancer (bowel cancer).

  • Cancer
  • Colorectal Cancer
  • World
  • Market Size
  • Merck & Co., Inc.
  • Breast Cancer Therapeutics Market, Global, Co-development Deals in Southeast Asia and Deals with Disclosed Values, 2006-
  • Breast Cancer Therapeutics Market, Global, All Pipeline Products, Phase I, 2016
  • Cancer
  • Asia
  • World
  • Market Size
  • Merck & Co., Inc.
  • 8.1 References
  • UROLOGIC ONCOLOGY THERAPEUTICS MARKET, GLOBAL, FORECAST MARKET SHARE BY
  • Cancer
  • Therapy
  • Urology
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 9.1.4 PHASE I
  • Guangzhou Medical University

Lung cancer is the most common cancer type in males.

  • Cancer
  • Lung Cancer
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • TREATING LUNG CANCER
  • Novel Therapies in Breast Cancer Treatment
  • Cancer
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • Novartis AG
  • 8.1 References
  • Oncology, Global, All Clinical Stage Pipeline Products, 2016

Cancer surgery: Physically removing cancer.

  • Cancer
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • Gastric Cancer Therapeutics Market, Global, All Pipeline Products, Phase III, 2016
  • Executive Summary
  • Cancer
  • Gastric Cancer
  • Therapy
  • Merck & Co., Inc.
  • Roche Group
  • Three major brands dominate the global cervical cancer market. A comparison of these brands is provided below.
  • Market landscape
  • Cancer
  • Cervical Cancer
  • Infectious Disease
  • Vaccine
  • Merck & Co., Inc.

Gastric cancer

4546 5000 3864
  • Pipeline: Gastric Cancer
  • Forecast: Gastric Cancer
  • Cancer
  • Chemotherapy
  • Gastric Cancer
  • Therapy
  • Merck & Co., Inc.

Head and neck cancer

4546 5000 3864

National Cancer Institute (2016) Head and Neck Cancer.

  • Cancer
  • Europe
  • Japan
  • World
  • Merck & Co., Inc.

Colorectal cancer

4546 5000 3864
  • LEADING TREATMENTS FOR COLORECTAL CANCER
  • LEADING TREATMENTS FOR COLORECTAL CANCER
  • Cancer
  • Chemotherapy
  • Colorectal Cancer
  • Therapy
  • Merck & Co., Inc.
  • C) Treatment population
  • 8.1 BIBLIOGRAPHY

SEER Cancer Statistics Factsheets: Ovary Cancer.

  • Cancer
  • Therapy
  • Vaccine
  • World
  • Merck & Co., Inc.
  • Forecast: Triple-Negative Breast Cancer
  • Pipeline: Triple-Negative Breast Cancer
  • Breast Cancer
  • Cancer
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • PANCREATIC CANCER THERAPEUTICS, GLOBAL, DEVELOPMENTAL PIPELINE, PHASE I, 2015
  • PANCREATIC CANCER THERAPEUTICS, GLOBAL, DEVELOPMENTAL PIPELINE, PHASE II, 2015
  • Cancer
  • Clinical Trial
  • Pancreatic Cancer
  • Therapy
  • Merck & Co., Inc.
  • PROSTATE CANCER THERAPEUTICS, GLOBAL, DEVELOPMENTAL PIPELINE, PHASE I, 2015
  • 8.1.1 PFIZER ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH MERCK
  • Cancer
  • Prostate Cancer
  • World
  • Forecast
  • Merck & Co., Inc.
  • 11: Prescription Skin Cancer Drugs
  • COMMON PRESCRIPTION TOPICAL, INTRALESIONAL AND OTHER SKIN CANCER AGENTS
  • Cancer
  • Dermatological Condition
  • Therapy
  • World
  • Merck & Co., Inc.
  • Five forces analysis

This type of cancer is further categorized by the affected areas such as oral cavity cancer, laryngeal cancer, pharyngeal cancer and other head and neck cancer.

  • Cancer
  • Ear, Nose, And Throat Medicine
  • World
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • 4.2.1 CERVICAL CANCER/ HPV - ADULT VACCINE MARKET AND FORECAST
  • 4.2 CERVICAL CANCER/ HPV - ADULT VACCINE ANALYSIS AND FORECAST (2007
  • Cancer
  • Infectious Disease
  • Vaccine
  • Demand
  • Merck & Co., Inc.
  • 08.1 PROPHYLACTIC CANCER VACCINES
  • 15. Market Growth Drivers
  • Cancer
  • Vaccine
  • World
  • Market Size
  • Merck & Co., Inc.
  • Scope of the report
  • Market landscape

In India, colon cancer is the ##th most common cancer among men.

  • Cancer
  • Colorectal Cancer
  • Therapy
  • Amgen Inc.
  • Merck & Co., Inc.

TYPES AND SYMPTOMS OF SKIN CANCER SKIN CANCER ACCOUNTS FOR OVER ##% OF ALL CANCERS.

  • Autoimmune Disease
  • Cancer
  • Dermatological Condition
  • Dermatology
  • Merck & Co., Inc.
  • LEADING TREATMENTS FOR BLADDER CANCER
  • BLADDER CANCER - LATE-STAGE PIPELINE, 2015
  • Bladder Cancer
  • Cancer
  • Hospital
  • Therapy
  • Merck & Co., Inc.